Holen Sie sich die Stockscreener-App
101.74
1.07%
1.08
Vorhandelsmarkt:
101.78
0.04
+0.04%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$100.66
Offen:
$100.88
24-Stunden-Volumen:
7.02M
Relative Volume:
0.67
Marktkapitalisierung:
$130.14B
Einnahmen:
$17.14B
Nettoeinkommen (Verlust:
$4.66B
KGV:
28.36
EPS:
3.588
Netto-Cashflow:
$3.79B
1W Leistung:
+2.13%
1M Leistung:
+12.43%
6M Leistung:
+24.83%
1J Leistung:
+10.94%
1-Tages-Spanne:
$100.73
$102.59
1-Wochen-Bereich:
$96.19
$102.59
52-Wochen-Spanne:
$56.32
$102.59
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Vergleichen Sie LRCX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
101.74 | 127.43B | 17.14B | 4.66B | 3.79B | 3.588 |
|
ASML
Asml Holding Nv
|
719.68 | 317.21B | 34.95B | 10.67B | 9.97B | 27.22 |
|
AMAT
Applied Materials Inc
|
192.61 | 158.17B | 28.09B | 6.76B | 5.86B | 8.22 |
|
KLAC
Kla Corp
|
937.76 | 121.91B | 11.55B | 3.70B | 3.51B | 27.51 |
|
TER
Teradyne Inc
|
94.82 | 15.28B | 2.91B | 577.07M | 608.44M | 3.54 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
Mainstay Capital Management LLC ADV Sells 2,963 Shares of Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Creekmur Asset Management LLC Acquires 8,100 Shares of Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Buckhead Capital Management LLC Purchases New Shares in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Lam Research Corporation (NASDAQ:LRCX) Position Boosted by Jackson Creek Investment Advisors LLC - MarketBeat
Diversify Advisory Services LLC Has $2.03 Million Position in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Lam Research Stock Climbs to 52-Week Peak at $102.32 - MSN
Nwam LLC Raises Holdings in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Lam Research (NASDAQ:LRCX) Reaches New 1-Year High Following Analyst Upgrade - MarketBeat
Lam Research (NASDAQ:LRCX) Given New $120.00 Price Target at UBS Group - MarketBeat
Crestwood Advisors Group LLC Boosts Stock Holdings in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Lam Research stock hits 52-week high at $102.32 By Investing.com - Investing.com India
Lam Research stock hits 52-week high at $102.32 - Investing.com Australia
Why Lam Research (LRCX) is a Top Stock for the Long-Term - Yahoo Finance
LRCX Soars 59% in Three Months: Is the Stock Still Worth Buying? - Yahoo Finance
Lam Research Corporation (NASDAQ:LRCX) Shares Acquired by Montag A & Associates Inc. - MarketBeat
UBS Raises Price Target for Lam Research (LRCX) on Positive Outl - GuruFocus
Montrusco Bolton Investments Inc. Purchases New Holdings in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Pictet Asset Management Holding SA Buys 224,391 Shares of Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Lam Research Corporation (NASDAQ:LRCX) Shares Acquired by Los Angeles Capital Management LLC - MarketBeat
Elyxium Wealth LLC Increases Position in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Victory Capital Management Inc. Sells 26,983 Shares of Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Migdal Insurance & Financial Holdings Ltd. Has $681,000 Holdings in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Lam Research (NASDAQ:LRCX) Shares Gap DownShould You Sell? - MarketBeat
Lam Research swaps 401(k) plan fixed-income investment options - Pensions & Investments
What analysts say about Lam Research Corporation stockExplosive capital gains - jammulinksnews.com
Stephens Inc. AR Boosts Stock Position in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
KeyCorp Increases Lam Research (NASDAQ:LRCX) Price Target to $115.00 - MarketBeat
OVERSEA CHINESE BANKING Corp Ltd Grows Stake in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Cutter & CO Brokerage Inc. Sells 5,384 Shares of Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
iShares Semiconductor ETF Experiences Significant Inflow, Micron Technology Down 4.2% - AInvest
67,997 Shares in Lam Research Corporation (NASDAQ:LRCX) Purchased by Securian Asset Management Inc. - MarketBeat
Peregrine Investment Management Inc. Raises Holdings in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Turtle Creek Wealth Advisors LLC Raises Stake in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
What makes Lam Research Corporation stock price move sharplySolid Return Trade Selections - beatles.ru
Why Lam Research (LRCX) Shares Are Trading Lower Today - TradingView
Wealthfront Advisers LLC Boosts Position in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Apollon Wealth Management LLC Raises Stock Position in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Bleakley Financial Group LLC Raises Position in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
New York State Common Retirement Fund Raises Stock Holdings in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Allworth Financial LP Boosts Stock Position in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Lam Research Corporation (NASDAQ:LRCX) Shares Purchased by Fortem Financial Group LLC - MarketBeat
KeyBanc Lifts Lam Research Price Target to $115 From $105, Maintains Overweight Rating - MarketScreener
LRCX: Keybanc Raises Price Target for Lam Research | LRCX Stock News - GuruFocus
Diversify Wealth Management LLC Grows Stake in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Lam Research (LRCX) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
Top IT Stocks Based on Warren Buffett's Strategy: ASML Holding and Lam Research Lead the Way - AInvest
Lam Research (NASDAQ:LRCX) Stock Price Expected to Rise, Mizuho Analyst Says - MarketBeat
Will ALD and Etch Deal Wins Anchor LRCX's Systems Revenue Growth? - The Globe and Mail
Hohimer Wealth Management LLC Has $3.48 Million Holdings in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Lam Research (LRCX) Sees Price Target Increase Amid Growing Dema - GuruFocus
Westmount Partners LLC Takes Position in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):